Respiratory Neurobiology: Physiology and Clinical Disorders, Part Two, Volume 189 is one of two volumes on the neurology of breathing. This volume focuses on pathologies attributable to abnormalities of the neural control of breathing, breathing problems that may occur in neurological diseases, and the neurological complications of respiratory diseases, while volume one focuses on the neurophysiology of breathing.

This book discusses the sources, human health hazards and risk prevention strategies associated with aeolian dust particles (fine and ultrafine) in the atmosphere. It covers the challenges of accurately forecasting aeolian dust and the need to raise public awareness on the warning signs and harmful impacts of airborne dust. Also discussed is the presence of microorganisms, heavy metals and other pollutants in dust which contributes to harmful impacts on human health as well as management and treatment options for the various health issues that can result from exposure. The book is a useful resource for scientists, engineers and policymakers interested in dust and health.

Non-invasive ventilation (NIV) involves the use of a mask to assist breathing for patients who can't breathe for themselves, providing an alternative to invasive ventilation, which involves the insertion of a tracheal tube into the throat of an unconscious patient. The procedure can be used for many problems involving breathing difficulties, such as lung disease and sleep apnea. This book provides a clear practical guide to medical practitioners on how to make use of NIV under various conditions - an approach that is easily applied. New additions to this second edition include chapters on cough-assist devices and non-invasive ventilation at home, along with an expansion of the chapters on long-term ventilation and physiotherapy. [Subject: Medicine]

This issue of Chest Medicine Clinics focuses on Interventional Pulmonology, with topics including: Flexible bronchoscopy; Radiology for mediastinal lymph node station in lung cancer diagnosis and staging; Lung cancer screening; Early lung cancer detection; Palliative care and interventional pulmonology; Anesthesia for flexible and rigid bronchoscopy; Mediastinal and pulmonary pathology: Specimen collection and processing; Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma; Bronchoscopic lung volume reduction; Malignant pleural effusion: From diagnostics to therapeutics; Intrapleural therapeutics; Percutaneous dilational tracheostomy; Tracheobronchial stenosis and Tracheobroncho malacia: diagnostic and therapeutic dilemmas; Pediatric interventional pulmonology; The Business of Bronchoscopy: How to set up an Interventional Pulmonology Program; Bronchoscopic therapies for peripheral lung malignancies; and Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma.

A concise review of the epidemiology, pathogenesis, and management of common respiratory conditions seen in a primary care setting. Using an illuminating case-based approach, Dr. Mintz assesses the key clinical questions that a primary care physician would ask and applies the most up-to-date research and guidelines to offer the practitioner evidence-based solutions. The author covers the range of knowledge needed to provide excellent care for patients with respiratory disease, from the basics of pulmonary function testing to understanding and caring for common respiratory illnesses, including chronic obstructive pulmonary disease, asthma, allergic rhinitis, and pneumonia. For each disorder, Dr. Mintz explains the key points regarding the epidemiology of the disease, its pathophysiology, the differential diagnosis and diagnosis, and its recommended treatment. A special PDA version of Disorders of the Respiratory Tract: Common Challenges in Primary Care is also available.

The pace of new research and level of innovation repeatedly introduced into the field of drug delivery to the lung is surprising given its state of maturity since the introduction of the pressurized metered dose inhaler over a half a century ago. It is clear that our understanding of pulmonary drug delivery has now evolved to the point that inhalation aerosols can be controlled both spatially and temporally to optimize their biological effects. These abilities include controlling lung deposition, by adopting formulation strategies or device technologies, and controlling drug uptake and release through sophisticated particle technologies. The large number of contributions to the scientific literature and variety of excellent texts published in recent years is evidence for the continued interest in pulmonary drug delivery research. This reference text endeavors to bring together the fundamental theory and practice of controlled drug delivery to the airways that is unavailable elsewhere. Collating and synthesizing the material in this rapidly evolving field presented a challenge and ultimately a sense of achievement that is hopefully reflected in the content of the volume.

Clinically focused and designed to provide a to-the-point overview, Interstitial Lung Disease, by Drs. Talmadge King, Harold Collard, and Luca Richeldi, bring you up to date with increased understanding, new treatment protocols, and recent advances in the field. Written by contributing specialists who are global experts in their respective areas, this one-stop reference provides pulmonologists, intensivists, internal medicine physicians, and researchers with a dependable source of information on current treatment options and patient care. . Evidence for current treatment options for interstitial pneumonia, idiopathic pulmonary fibrosis, and smoking-related interstitial lung diseases. . Approach to diagnosis of interstitial lung diseases, such as sarcoidosis, hypersensitivity pneumonitis, and Churg-Strauss syndrome. . Genetic markers for inherited interstitial lung diseases such as dyskeratosis congenita, tuberous sclerosis/LAM, and hyper-IgE syndrome. . Expert ConsultT eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Diagnostic imaging is an essential component in the evaluation of the patient with known or suspected respiratory tract disease. While chest radiography continues to serve as the primary tool for imaging the chest, advances in computed tomography (CT) have led to a variety of applications such as high-resolution CT (HRCT), advanced 3-D airway imaging, and image-guided procedures. The aim of this book is to deliver a clinically-oriented approach to pulmonary imaging. Each chapter of the book will provide an organized approach to the different facets of imaging of specific clinical scenarios, focusing on strengths and weaknesses of available imaging tests. High quality examples of typical imaging findings of specific conditions will supplement the text. The target readers include practicing internists, pulmonologists, thoracic surgeons, and primary care practitioners. Other readers will include respiratory care therapists and medical students. The proposed cohort of authors represents experts in the field of thoracic radiology. These authors have experience in thoracic radiology and medical writing, each will deliver a high-quality chapter meeting the aims and scope of this book while addressing the target audience. Aside from the first three chapters, which are introductory materials, each author will be invited to select a clinician with whom they work closely to serve as a co-author in order to provide a chapter that maintains the clinical orientation of this book.

This issue of Clinics in Chest Medicine focuses on Pulmonary Complications of Non-Pulmonary Malignancy. Editors Guang-Shing Cheng and Jennifer Possick have assembled an expert team of authors on topics such as: Pulmonary manifestations of non-pulmonary solid malgnancies; Pulmonary manifestations of leukemia and lymphoma; Radiation pneumonitis; Toxicities from conventional chemotherapy; Toxicities from novel targeted therapies; Bacterial pneumonia; Fungal pneumonia; Viral pneumonia; IPS and other early onset non-infectious pulmonary syndromes; Pulmonary GVHD and other late-onset non-infectious pulmonary syndromes; Pulmonary function and pre-transplant risk assessment; Diagnostic Evaluation of Pulmonary Abnormalities in Hematologic Malignancy and HCT; Acute respiratory failure in patients with non-pulmonary malignancy; Critical care prognosis and outcomes in patients with non-pulmonary malignancy; and Palliative and end-of-life care.

This book gives a comprehensive overview on the use of image-guided radiation therapy (IGRT) in the treatment of lung cancer, covering step-by-step guidelines for clinical implementations, fundamental principles and key technical advances. It covers benefits and limitations of techniques as well as quality and safety issues related to IGRT practice. Addresses imaging simulation, treatment planning, verification, and delivery Discusses important quality assurance issues Describes current methods using specialized machines and technologies Jing Cai, PhD, is an Associate Professor of Radiation Oncology at Duke University Medical Center. Joe Y. Chang, MD, PhD, is Professor in the Department of Radiation Oncology at The University of Texas MD Anderson Cancer Center in Houston. Fang-Fang Yin, PhD, is Chief of the Division of Radiation Physics, Professor of Radiation Oncology, and Director of the Medical Physics program at Duke University.

Dr. Goldsworthy has created a state-of-the-art issue that emphasizes the nurse's role in mechanical ventilation. Pertinent clinical topics include the following: basics of mechanical ventilation for nurses; current modes for mechanical ventilation; best practices for managing pain, sedation, and delirium in the mechanically ventilated patient; mobilization of and optimal oxygenation for the mechanicaly ventilated patient; managing complications; and effective weaning strategies. Authors also address mechanical ventilation in both children and neonates. The current content in this issue will leave nurses with the clinical information they need to effectively manage mechanically ventilated patients.

This issue of Clinics in Chest Medicine focuses on Advances in Mechanical Ventilation. Articles include: Mechanical Ventilation Design Features; Assessing Respiratory System Mechanical Function; Ventilator Induced Lung Injury; Managing Acute Lung Injury; Patient-Ventilator Interactions; Extracorporeal Gas Exchange; Preventing Ventilator Associated Infections; Ventilator Discontinuation Process; Ventilator Management of the Non-injured Lung; Non-invasive Ventilation; and more!

This issue of Immunology and Allergy Clinics, guest edited by Dr. Andrew A. White, is devoted to Aspirin-Exacerbated Respiratory Disease. Articles in this issue include: An Overview of Non-Steroidal Anti-inflammatory Drug Reactions; The Clinical Presentation of Aspirin-Exacerbated Respiratory Disease; Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease; Aspirin-Exacerbated Respiratory Disease as an Endotype of Chronic Rhinosinusitis; Pathogenesis of Aspirin Reactions in Aspirin-Exacerbated Respiratory Disease; Performing Aspirin Desensitization; Clinical Trials in Aspirin-Exacerbated Respiratory Disease Treatment; Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease; Mechanisms of Benefit with Aspirin Therapy; Lipid Mediators in Aspirin-Exacerbated Respiratory Disease; and Epigenetic and Genetic Components of Aspirin-Exacerbated Respiratory Disease.

Respiratory problems are the most common cause of acute admission to hospital. A variety of diagnostic investigations are required, both for acute and clinic assessment. Making Sense of Lung Function Tests, Second Edition familiarises both trainees and more experienced clinicians with the interpretation of a range of respiratory parameters. It places lung function in a clinical context using real-life examples and provides invaluable hands-on guidance. For this second edition Consultant Respiratory Physician Jonathan Dakin and Consultant Anaesthetist Elena Kourteli are joined by Mark Mottershaw, Chief Respiratory Physiologist from Queen Alexandra Hospital, Portsmouth, all contributing a broad range of expertise and perspectives. Together they have updated the book throughout and added new chapters including an algorithm for interpretation of pulmonary function tests, exhaled nitric oxide (FENO) and cardiopulmonary exercise testing. The text offers a clear explanation of the concepts which students find difficult, including: The basis of obstructive and restrictive defects Pattern recognition of the flow volume loop Differences between TLCO and KCO Assessment of oxygenation using PO2 and SO2 The basis of Type 1 and type 2 respiratory failure Distinguishing respiratory and metabolic acidosis The relationship between sleep and respiratory failure The information is presented in an accessible way, suitable for those seeking a basic grounding in spirometry or blood gases, but also sufficiently comprehensive for readers completing specialist training in general or respiratory medicine.

Preterm birth interrupts the normal developmental progression of most organs, particularly when birth occurs at the lowest level of viability. An immediate task is to successfully transition to a post-natal life without a placental circulation. To do this demands careful management of the cardiorespiratory systems. To best help the fragile preterm infant at this demanding time, care-givers must remember two most pressing goals. These are first to maintain adequacy of gas exchange and delivery, while simultaneously minimizing any secondary injury to the fragile preterm lung. However, after these immediate priorities in the delivery room, the longer term effects of an immature lung development and its associated problems come to the forefront. These problems include the inflammation of perinatal infection, oxygen, and invasive mechanical ventilation. Both the immaturity itself, and secondary lung injury and its inflammation - collectively will often lead to the condition termed bronchopulmonary dysplasia (BPD). Although many of these infants may eventually be discharged to home without a need for oxygen supplementation or pulmonary medications, the long-term impact of interrupted lung development and secondary lung injury remain serious concerns. It is now well recognized that mechanical ventilation is pivotal to developing secondary lung injury and BPD. Consequently, a great deal of time and effort has been put into the development and application of non-invasive ventilator (NIV) approaches to supporting respiratory function in neonates. Since the landmark publication by Gregory and colleagues in 1967, nasal continuous positive airway pressure (nCPAP) has been the most commonly applied approach to NIV. This approach has been supported by the recent generation of randomized controlled trials. However, cumulatively these trials have shown only a small reduction in rates of BPD. Outside of the trial data, despite the wider application of nCPAP, rates of BPD remain relatively unchanged over recent years. This has led to investigations of other NIV approaches including nasal ventilation and high flow nasal cannula therapy. Not only have available modes increased, but so have the interfaces through which these modes may be applied. In the issue of Clinic in Perinatology, readers will find an up-to-date review of non-invasive approaches to supporting preterm respiratory function. This draws on the expertise of leading investigators in the field. This issue reviews the physiologic mechanisms by which the various approaches to NIV may support respiratory function; the evidence base supporting different NIV approaches; and adjunctive aspects of NIV therapy including their use during neonatal transport and the application of other supportive therapies such as inhaled NO.

Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach is an excellent resource for clinicians who care for individuals affected by alcohol use disorders in diverse settings. Although alcohol abuse alone does not cause acute lung injury, it renders the lung susceptible to dysfunction in response to the inflammatory stresses of sepsis, trauma, and other clinical conditions recognized to cause acute lung injury. In parallel, these same pathophysiological effects of alcohol abuse significantly increase the risk of a wide range of serious lung infections. Many clinicians involved in the primary treatment of alcohol use disorders, such as addiction psychiatrists, will find this text of interest as it will expand their understanding of the health consequences of alcohol use disorders. In parallel, clinicians who specialize in pulmonary and/or critical care medicine will have a unique resource that provides a comprehensive review of the pathophysiology of alcohol-related lung disorders and insights into evolving therapeutic options in these vulnerable individuals. Alcohol Use Disorders and the Lung: A Clinical and Pathophysiological Approach fills a gap in the literature and presents the evolving clinical research that may soon lead to novel therapies that can improve lung health in individuals with alcohol use disorders and co-existing conditions such as HIV infection.

Mitochondria, often referred to as the "powerhouses" of the cell, generate adenosine triphosphate (ATP) by oxidative phosphorylation or OXPHOS, and maintain cellular homeostasis. In addition to generating ATP, mitochondria are involved in regulation of cell cycle, proliferation, free radical production, innate immune responses and apoptosis. Mitochondrial Function in Lung Health and Disease fills the current gap in the literature and outlines the growing clinical relevance of mitochondrial dysfunction. Currently, there is no overview on the role of mitochondria in pulmonary diseases and this volume focuses on the mitochondrial metabolism, redox signaling, and mechanisms of mitochondrial pathways in lung injury, inflammation, repair and remodeling. Furthermore, in addition to their well-recognized role in cellular energy production and apoptosis, mitochondria appear to play a role in many respiratory diseases and lung cancer. Chapters are written by top notch researchers and clinicians and outline the evidence for mitochondrial biogenesis in inhalational lung injury, COPD and asthma.

This book aims to be a complete guide to diagnose, manage and treat rare lung diseases encountered by practising pulmonologists and trainees. It extensively covers the "more common" of the rare lung diseases, categorising them based on developmental lung anomalies in adults, airway disorders, diffuse parenchymal lung diseases, neoplasms, rare vascular disorders and other miscellaneous conditions. This comprehensive review facilitates the study and understanding of this complex and diverse set of disorders, focussing on differential diagnosis, evidence-based discussions of management algorithms, and thoughtful analysis of treatment options. Key Features: 1. Reviews multiple rare lung diseases, including ones acquired congenitally to be expressed in old age. 2. Enriched with case studies and illustrations, guides the respiratory physicians and trainees to devise an effective treatment plan. 3. Focuses on concerned investigations, with a section on role of new procedures in the management.

This volume provides a comprehensive and multi-disciplinary overview of the aging lung, written by the main researchers in the field. Current physiological, cellular and molecular understanding of how the lungs age and the relationship to age-associated lung diseases will be presented. The contents are aimed at a broad audience of scientists and clinicians with an interest in the respiratory system, pathogenesis of age-associated lung diseases and clinical implications.

This issue of Sleep Medicine Clinics, guest-edited by Dr. Jessie Bakker, focuses on Unraveling the Puzzle of Adherence in Sleep Medicine. This issue is one of four selected each year by series Consulting Editors, Dr. Teofilo Lee-Chiong and Dr. Ana C Krieger. Articles include: What can we consider to be a clinically meaningful target for PAP adherence?, Adherence to sleep therapies in children and adolescents, Socioeconomic Disparities in Positive Airway Pressure Adherence: An Integrative Review, What do we know about adherence to oral appliances?, Alternative care pathways for OSA and the impact on PAP adherence, Summary and Update on Behavioural Interventions for Improving Adherence with Positive Airway Pressure Treatment in Adults and more.

This is the only book dedicated solely to frontal sinus disorders. It is a richly illustrated and comprehensive mine of information on the anatomy and management of these disorders. This updated second edition offers much new information. Additional topics include balloon dilation, frontal surgery as part of skull base surgery, and advances in endoscopic techniques and tools that have occurred since 2004 and have made open osteoplastic procedures almost obsolete. The anatomy and surgery of the supraorbital ethmoid cell and its significance in the pathology of frontal sinus disease are also covered. Throughout the book, particularly important areas of text are highlighted and core messages, emphasized. Videos of described procedures are available online.

Extracorporeal membrane oxygenation (ECMO) has been in clinical use for some 40 years, but it is only in the past decade that its application in the treatment of life-threatening circulatory and respiratory failure has truly flourished. This book presents a comprehensive overview of both pathophysiological and practical aspects of circulatory and respiratory extracorporeal support. The basics of ECMO, including its history, the "ECMO team," cannulation, materials, and blood- surface interactions, are first discussed. The various indications for and particular characteristics of circulatory and respiratory extracorporeal life support are then described in detail in the main part of the book. Patient care during ECMO and monitoring of the ECMO patient are also carefully covered, with explanation of the management of technical and clinical complications and transport-related problems. Further topics include long-term therapy options beyond ECMO, such as ventricular assist devices and transplants, outcome, the new frontiers of ECMO for organ procurement and future challenges. The authors are well-known experts in the field whose authoritative contributions and attention to practical aspects will be invaluable for novices and experienced practitioners alike.

This book provides a comprehensive overview of how to use MRI for the imaging of lung disease. Special emphasis is placed on routine applications and the clinical impact of MRI in each setting. In addition, current technological developments are reviewed and information presented on dedicated applications of MRI in preclinical and translational research, clinical trials, and specialized institutions. During the past two decades, significant advances in the technology have enabled MRI to enter and mature in the clinical arena of chest imaging. Standard protocols are now readily available on MR scanners, and MRI is recommended as the first- or second-line imaging modality for a variety of lung diseases, not limited to cystic fibrosis, pulmonary hypertension, and lung cancer. The benefits and added value of MRI originate from its ability to both visualize lung structure and provide information on different aspects of lung function, such as perfusion, respiratory motion, ventilation, and gas exchange. On this basis, novel quantitative surrogates for lung function and therapy control (imaging biomarkers) are generated. The second edition of MRI of the Lung has been fully updated to take account of recent advances. It is written by an internationally balanced team of renowned authors representing all major groups in the field.